3/13
12:29 pm
fulc
Rating for FULC
Low
Report
Rating for FULC
3/13
12:29 pm
fulc
Rating for FULC
Low
Report
Rating for FULC
3/13
08:15 am
fulc
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $14.00 price target on the stock.
Low
Report
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $14.00 price target on the stock.
3/13
08:15 am
fulc
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $14.00 price target on the stock.
Low
Report
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $14.00 price target on the stock.
3/13
07:28 am
fulc
Fulcrum Therapeutics initiated with bullish view at RBC Capital
Low
Report
Fulcrum Therapeutics initiated with bullish view at RBC Capital
3/13
07:28 am
fulc
Fulcrum Therapeutics initiated with bullish view at RBC Capital
Low
Report
Fulcrum Therapeutics initiated with bullish view at RBC Capital
1/26
09:27 am
fulc
Rating for FULC
Low
Report
Rating for FULC
1/26
09:27 am
fulc
Rating for FULC
Low
Report
Rating for FULC
1/26
09:27 am
fulc
Rating for FULC
Low
Report
Rating for FULC
1/25
09:07 am
fulc
Rating for FULC
Medium
Report
Rating for FULC
1/25
09:07 am
fulc
Rating for FULC
Medium
Report
Rating for FULC
1/25
09:07 am
fulc
Rating for FULC
Medium
Report
Rating for FULC